ID: ALA5192222

Max Phase: Preclinical

Molecular Formula: C48H82N12O16

Molecular Weight: 1083.25

Associated Items:

Representations

Canonical SMILES:  CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)O

Standard InChI:  InChI=1S/C48H82N12O16/c1-10-24(7)37(45(72)53-28(19-32(51)61)41(68)55-30(21-34(64)65)47(74)60-18-14-16-31(60)48(75)76)58-39(66)26(9)52-43(70)35(22(3)4)57-46(73)38(25(8)11-2)59-42(69)29(20-33(62)63)54-44(71)36(23(5)6)56-40(67)27(50)15-12-13-17-49/h22-31,35-38H,10-21,49-50H2,1-9H3,(H2,51,61)(H,52,70)(H,53,72)(H,54,71)(H,55,68)(H,56,67)(H,57,73)(H,58,66)(H,59,69)(H,62,63)(H,64,65)(H,75,76)/t24-,25-,26-,27-,28-,29-,30-,31-,35-,36-,37-,38-/m0/s1

Standard InChI Key:  NQEJDXWZOONROE-FGUQEMMXSA-N

Associated Targets(Human)

MKN-7 272 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1083.25Molecular Weight (Monoisotopic): 1082.5972AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Yoshida J, Takayama K, Kawada M..  (2022)  Short peptides derived from hGAPDH exhibit anti-cancer activity.,  71  [PMID:35964520] [10.1016/j.bmc.2022.116953]

Source